VITALE, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 8.422
EU - Europa 3.372
AS - Asia 2.753
SA - Sud America 438
AF - Africa 42
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.032
Nazione #
US - Stati Uniti d'America 8.341
GB - Regno Unito 1.421
CN - Cina 1.015
SG - Singapore 883
IT - Italia 466
BR - Brasile 368
HK - Hong Kong 357
SE - Svezia 353
DE - Germania 289
RU - Federazione Russa 160
UA - Ucraina 156
VN - Vietnam 150
FI - Finlandia 121
FR - Francia 114
KR - Corea 92
TR - Turchia 87
IE - Irlanda 83
BG - Bulgaria 66
CA - Canada 47
IN - India 44
AR - Argentina 26
ID - Indonesia 26
NL - Olanda 23
MX - Messico 20
ZA - Sudafrica 19
BD - Bangladesh 18
BE - Belgio 18
ES - Italia 17
MY - Malesia 15
BY - Bielorussia 13
EC - Ecuador 13
JP - Giappone 11
PL - Polonia 11
CL - Cile 9
LT - Lituania 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
PT - Portogallo 7
PY - Paraguay 7
VE - Venezuela 7
CO - Colombia 6
RO - Romania 6
UZ - Uzbekistan 6
AT - Austria 5
PK - Pakistan 5
DO - Repubblica Dominicana 4
HU - Ungheria 4
IL - Israele 4
MA - Marocco 4
SA - Arabia Saudita 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
EG - Egitto 3
IQ - Iraq 3
KZ - Kazakistan 3
NO - Norvegia 3
SI - Slovenia 3
AU - Australia 2
CR - Costa Rica 2
DZ - Algeria 2
JO - Giordania 2
LU - Lussemburgo 2
LY - Libia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
AD - Andorra 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
Totale 15.030
Città #
Southend 1.111
Fairfield 804
Santa Clara 788
Ashburn 765
Woodbridge 562
Singapore 534
Chandler 464
Houston 406
Hefei 366
Seattle 356
Hong Kong 351
Jacksonville 347
Dearborn 291
Wilmington 291
Cambridge 290
Ann Arbor 288
Chicago 239
Nyköping 201
Beijing 182
Los Angeles 172
London 158
Modena 115
Salt Lake City 87
New York 84
Dublin 83
Seoul 76
Princeton 75
Council Bluffs 70
San Diego 67
Sofia 63
Helsinki 58
Eugene 57
Dallas 55
The Dalles 54
Izmir 53
Moscow 47
Buffalo 46
Ho Chi Minh City 43
Elk Grove Village 42
Des Moines 39
São Paulo 37
Bremen 32
Tampa 30
Frankfurt am Main 29
Munich 29
Milan 28
Redwood City 28
Fremont 27
Toronto 27
Phoenix 26
Boardman 24
Falls Church 24
Hanoi 24
Lancaster 24
San Jose 22
Columbus 21
Sterling 21
Shanghai 20
Brooklyn 19
Norwalk 17
Brussels 16
Miami 16
Pittsburgh 14
Bologna 13
Detroit 13
Jakarta 13
Rome 13
Seongnam 13
Parma 12
Johannesburg 11
Kansas City 11
Paris 11
Poplar 11
Warsaw 11
Wuhan 11
Biên Hòa 10
Chennai 10
Kent 10
Nanjing 10
Naples 10
Rio de Janeiro 10
Tokyo 10
Denver 9
Dong Ket 9
Dulles 9
Orem 9
Atlanta 8
Formia 8
Guayaquil 8
Hounslow 8
Montreal 8
Reggio Emilia 8
San Mateo 8
Ankara 7
Brasília 7
Gif-sur-Yvette 7
Hangzhou 7
Jinan 7
Newark 7
Redondo Beach 7
Totale 11.089
Nome #
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 453
ANXIOLYTIC LIKE EFFECT OF NEUROPEPTIDE S IN THE RAT DEFENSIVE BURYING. 389
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 381
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 377
Acute noise stress analgesia in relation to 5-HT2 and mu-opioid receptor changes in the frontal cortex of young mice 375
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 349
Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. 333
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 325
Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet 301
Collagen VI regulates peripheral nerve regeneration by modulating macrophage recruitment and polarization 299
Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation. 297
Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats 295
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 295
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 292
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies. 290
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 284
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 284
Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 280
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 268
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 263
Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system 261
Gamma-hydroxybutyrate increases gastric emptying in rats 249
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 245
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 241
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 241
Headaches associated with chronic use of analgesics: A therapeutic approach 237
BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5alpha-Dihydroprogesterone and Pregnanolone Level 234
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 233
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 233
Effect of rofecoxib on nociception and the serotonin system in the rat brain 231
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505 231
Disposition of naproxen after oral administration during and between migraine attacks. 228
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 226
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 225
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 223
In vitro toxicity of fibrous glaucophane 222
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 221
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 217
Acute cytotoxicity of mineral fibres observed by time-lapse video microscopy 208
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 204
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 204
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 202
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 201
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 198
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 196
Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress 195
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 192
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 191
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 185
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 178
Glutamate-mediated astrocyte-to-neuron signaling in the rat dorsal horn 176
Disclosing the Antioxidant and Neuroprotective Activity of an Anthocyanin-Rich Extract from Sweet Cherry (Prunus avium L.) Using In Vitro and In Vivo Models 172
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 169
Chronic treatment with phenazone modifies pontine noradrenergic receptors in rats. 167
Effect of hypericum perforatum extract in an experimental model of binge eating in female rats 166
Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis 165
EFFECTS OF ACETYLSALICYCLIC ACID ON SEROTONIN BRAIN RECEPTOR SUBTYPES 159
Naloxone-reverisble antinociception by paracetamol in the rat. 150
Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes 149
Naltrexone and 6-Beta-naltrexol concentration/time profile in the treatment of opiate dependence 145
Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis 136
Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis 129
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study 111
Chemical Characterization and Beneficial Effects of Walnut Oil on a Drosophila melanogaster Model of Parkinson’s Disease 106
Characterization of Walnut Oil and Evaluation of Its Neuroprotective Effects in an In Vitro Model of Parkinson’s Disease 51
Totale 15.133
Categoria #
all - tutte 61.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021853 0 0 0 0 0 130 106 169 63 209 89 87
2021/20221.318 40 156 157 76 37 37 101 64 148 99 257 146
2022/20231.341 163 152 86 124 147 207 22 118 137 30 55 100
2023/2024650 36 36 49 54 162 43 34 93 11 17 52 63
2024/20252.692 86 16 44 176 566 388 225 136 298 160 293 304
2025/20263.466 405 273 437 779 1.126 446 0 0 0 0 0 0
Totale 15.133